Aktive Positionen von Marc Chevrel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Arbiom, Inc.
 Arbiom, Inc. BiotechnologyHealth Technology Arbiom, Inc. engages in the development of technology that transforms the use of wood into a supply of protein with amino acid content for animal feed. Its product Arbiom SylPro is a single-cell protein yeast with amino acid profile and digestibility. The company is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
Arbiom SAS
 Arbiom SAS Pharmaceuticals: MajorHealth Technology Biométhodes SA develops a technology in engineering and optimization of enzymes. It offers chemical pretreatment of non-food biomass and bio-refinery process. The company was founded in 1997 and is headquartered in Evry, France. | Vorsitzender | 25.05.2017 | - |
Karriereverlauf von Marc Chevrel
Statistik
International
| Vereinigte Staaten | 2 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Arbiom, Inc.
Arbiom, Inc. BiotechnologyHealth Technology Arbiom, Inc. engages in the development of technology that transforms the use of wood into a supply of protein with amino acid content for animal feed. Its product Arbiom SylPro is a single-cell protein yeast with amino acid profile and digestibility. The company is headquartered in Durham, NC. | Health Technology |
Arbiom SAS
Arbiom SAS Pharmaceuticals: MajorHealth Technology Biométhodes SA develops a technology in engineering and optimization of enzymes. It offers chemical pretreatment of non-food biomass and bio-refinery process. The company was founded in 1997 and is headquartered in Evry, France. | Health Technology |
- Börse
- Insiders
- Marc Chevrel
- Erfahrung
